"We are extremely proud to play a critical role in this clinical trial with the UNITY Fetal Antigen CTA test" said Oguzhan Atay, PhD, CEO of BillionToOne. "The ability to detect fetal antigens as ...
The false negative rates do not appear out of line with the test's sensitivity figures, but issues have been raised with its workflow and the firm's marketing strategy.
On 6 February 2023, Janssen announced via press release positive results for its investigational drug nipocalimab for the treatment of pregnant adults at high risk for severe hemolytic disease of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback